SGLT2 inhibitors reduced total cardiovascular risk by 18% in type 2 diabetes, with greatest benefit in patients at high risk for CVD recurrence. In patients with type 2 diabetes, sodium-glucose ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being ...

The incidence rates of 14 cancers have increased in early-onset age groups, with increases in older-onset age groups also ...

Few studies examine how people living with a mental illness may be best prepared for the menopause transition, considering ...

Individuals with Down syndrome are at increased risk of poor cardiovascular outcomes, according to a study published online ...

Shorter breastfeeding duration and younger age at first birth are known risk factors for triple negative breast cancer (TNBC) ...

Physical activity (PA) and participation in organized sports may offer protective effects against childhood psychiatric ...

In a clinical report published in the May issue of Pediatrics, the American Academy of Pediatrics presents updated guidance ...

The U.S. Department of Health and Human Services and U.S. Food and Drug Administration have begun to comprehensively review ...

Treatment of Alzheimer disease with lecanemab is feasible in a specialty memory clinic, and the frequency of significant ...

Preinjury mobility data predicts recovery following a lower-extremity fracture in adults, according to a proof-of-concept ...

Among patients with cardiogenic shock, vasopressin administration in the first 24 hours was linked to lower in-hospital ...